Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study

被引:77
作者
Laiteerapong, Neda [1 ]
Karter, Andrew J. [2 ]
Moffet, Howard H. [2 ]
Cooper, Jennifer M. [1 ]
Gibbons, Robert D. [3 ,4 ]
Liu, Jennifer Y. [2 ]
Gao, Yue [1 ]
Huang, Elbert S. [1 ]
机构
[1] Univ Chicago, Sect Gen Internal Med, Dept Med, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA
[2] Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA
[3] Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 2000, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Publ Hlth Sci, 5841 S Maryland Ave,MC 2000, Chicago, IL 60637 USA
关键词
Epidemiology; Legacy effect; Microvascular disease; Mortality; Glycemic control; FASTING PLASMA-GLUCOSE; ALL-CAUSE MORTALITY; GLYCEMIC VARIABILITY; CARDIOVASCULAR-DISEASE; HBA1C VARIABILITY; FOLLOW-UP; RISK; ASSOCIATION;
D O I
10.1016/j.jdiacomp.2016.07.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To classify trajectories of long term HbAlc values in patients after diagnosis of type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality. Methods: A longitudinal follow-up of 28,016 patients newly diagnosed with type 2 diabetes was conducted. Latent growth mixture modeling was used to identify ten-year HbA1c trajectories. Cox proportional hazards models were used to assess how HbAlc trajectories were associated with events (microvascular and macrovascular) and mortality. Results: We identified 5 HbAlc trajectories: "low stable" (82.5%), "moderate increasing late" (5.1%), "high decreasing early" (4.9%), "moderate peaking late" (4.1%) and "moderate peaking early" (3.3%). After adjusting for average HbAlc, compared to the low stable trajectory, all non-stable trajectories were associated with higher incidences of microvascular events (hazard ratio (HR) range, 1.28 (95% CI, 1.08-1.53) (high decreasing early) to 1.45 (95% CI, 1.20-1.75) (moderate peaking early)). The high decreasing early trajectory was associated with an increased mortality risk (HR, 1.27 (95% Cl, 1.03-1.58)). Trajectories were not associated with macrovascular events. Conclusions: Non-stable HbA1c trajectories were associated with greater risk of microvascular events and mortality. These findings suggest a potential benefit of early diabetes detection, prioritizing good glycemic control, and maintaining control over time. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 31 条
[1]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[2]   'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting [J].
Ceriello, A. ;
Ihnat, M. A. .
DIABETIC MEDICINE, 2010, 27 (08) :862-867
[3]   Glycemic Variability: Both Sides of the Story [J].
Ceriello, Antonio ;
Kilpatrick, Eric S. .
DIABETES CARE, 2013, 36 :S272-S275
[5]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[6]   Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients [J].
Gimeno-Orna, JA ;
Castro-Alonso, FJ ;
Boned-Juliani, B ;
Lou-Arnal, LM .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (02) :78-81
[7]   The Cardiovascular Safety of Diabetes Drugs - Insights from the Rosiglitazone Experience [J].
Hiatt, William R. ;
Kaul, Sanjay ;
Smith, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14) :1285-1287
[8]   Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial [J].
Hirakawa, Yoichiro ;
Arima, Hisatomi ;
Zoungas, Sophia ;
Ninomiya, Toshiharu ;
Cooper, Mark ;
Hamet, Pavel ;
Mancia, Giuseppe ;
Poulter, Neil ;
Harrap, Stephen ;
Woodward, Mark ;
Chalmers, John .
DIABETES CARE, 2014, 37 (08) :2359-2365
[9]   10-year follow-up of intensive glucose control in type 2 diabetes [J].
Holman, Rury R. ;
Paul, Sanjoy K. ;
Bethel, M. Angelyn ;
Matthews, David R. ;
Neil, H. Andrew W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1577-1589
[10]   HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study [J].
Hsu, C. C. ;
Chang, H. Y. ;
Huang, M. C. ;
Hwang, S. J. ;
Yang, Y. C. ;
Lee, Y. S. ;
Shin, S. J. ;
Tai, T. Y. .
DIABETOLOGIA, 2012, 55 (12) :3163-3172